261 related articles for article (PubMed ID: 23235148)
61. "STRESSED OUT": The role of FUS and TDP-43 in amyotrophic lateral sclerosis.
Aksoy YA; Deng W; Stoddart J; Chung R; Guillemin G; Cole NJ; Neely GG; Hesselson D
Int J Biochem Cell Biol; 2020 Sep; 126():105821. PubMed ID: 32758633
[TBL] [Abstract][Full Text] [Related]
62. Rab1-dependent ER-Golgi transport dysfunction is a common pathogenic mechanism in SOD1, TDP-43 and FUS-associated ALS.
Soo KY; Halloran M; Sundaramoorthy V; Parakh S; Toth RP; Southam KA; McLean CA; Lock P; King A; Farg MA; Atkin JD
Acta Neuropathol; 2015 Nov; 130(5):679-97. PubMed ID: 26298469
[TBL] [Abstract][Full Text] [Related]
63. Post-transcriptional Inhibition of Hsc70-4/HSPA8 Expression Leads to Synaptic Vesicle Cycling Defects in Multiple Models of ALS.
Coyne AN; Lorenzini I; Chou CC; Torvund M; Rogers RS; Starr A; Zaepfel BL; Levy J; Johannesmeyer J; Schwartz JC; Nishimune H; Zinsmaier K; Rossoll W; Sattler R; Zarnescu DC
Cell Rep; 2017 Oct; 21(1):110-125. PubMed ID: 28978466
[TBL] [Abstract][Full Text] [Related]
64. Temporal Expression of Mutant TDP-43 Correlates with Early Amyotrophic Lateral Sclerosis Phenotype and Motor Weakness.
Chen Q; Zhou J; Huang C; Huang B; Bi F; Zhou H; Xiao B
Curr Neurovasc Res; 2018; 15(1):3-9. PubMed ID: 29313467
[TBL] [Abstract][Full Text] [Related]
65. Amyotrophic lateral sclerosis-linked mutant VAPB enhances TDP-43-induced motor neuronal toxicity.
Suzuki H; Matsuoka M
J Neurochem; 2011 Dec; 119(5):1099-107. PubMed ID: 21933185
[TBL] [Abstract][Full Text] [Related]
66. Immunoreactivity of valosin-containing protein in sporadic amyotrophic lateral sclerosis and in a case of its novel mutant.
Ayaki T; Ito H; Fukushima H; Inoue T; Kondo T; Ikemoto A; Asano T; Shodai A; Fujita T; Fukui S; Morino H; Nakano S; Kusaka H; Yamashita H; Ihara M; Matsumoto R; Kawamata J; Urushitani M; Kawakami H; Takahashi R
Acta Neuropathol Commun; 2014 Dec; 2():172. PubMed ID: 25492614
[TBL] [Abstract][Full Text] [Related]
67. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis.
Kwiatkowski TJ; Bosco DA; Leclerc AL; Tamrazian E; Vanderburg CR; Russ C; Davis A; Gilchrist J; Kasarskis EJ; Munsat T; Valdmanis P; Rouleau GA; Hosler BA; Cortelli P; de Jong PJ; Yoshinaga Y; Haines JL; Pericak-Vance MA; Yan J; Ticozzi N; Siddique T; McKenna-Yasek D; Sapp PC; Horvitz HR; Landers JE; Brown RH
Science; 2009 Feb; 323(5918):1205-8. PubMed ID: 19251627
[TBL] [Abstract][Full Text] [Related]
68. MTHFSD and DDX58 are novel RNA-binding proteins abnormally regulated in amyotrophic lateral sclerosis.
MacNair L; Xiao S; Miletic D; Ghani M; Julien JP; Keith J; Zinman L; Rogaeva E; Robertson J
Brain; 2016 Jan; 139(Pt 1):86-100. PubMed ID: 26525917
[TBL] [Abstract][Full Text] [Related]
69. Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments.
Swarup V; Phaneuf D; Bareil C; Robertson J; Rouleau GA; Kriz J; Julien JP
Brain; 2011 Sep; 134(Pt 9):2610-26. PubMed ID: 21752789
[TBL] [Abstract][Full Text] [Related]
70. A novel mutation in the cleavage site N291 of TDP-43 protein in a familial case of amyotrophic lateral sclerosis.
Chami AA; Beltran S; Corcia P; Andres CR; Laumonnier F; Blasco H; Vourc'H P
Amyotroph Lateral Scler Frontotemporal Degener; 2020 Aug; 21(5-6):463-466. PubMed ID: 32301341
[TBL] [Abstract][Full Text] [Related]
71. TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration.
Wegorzewska I; Bell S; Cairns NJ; Miller TM; Baloh RH
Proc Natl Acad Sci U S A; 2009 Nov; 106(44):18809-14. PubMed ID: 19833869
[TBL] [Abstract][Full Text] [Related]
72. Mutant TDP-43 within motor neurons drives disease onset but not progression in amyotrophic lateral sclerosis.
Ditsworth D; Maldonado M; McAlonis-Downes M; Sun S; Seelman A; Drenner K; Arnold E; Ling SC; Pizzo D; Ravits J; Cleveland DW; Da Cruz S
Acta Neuropathol; 2017 Jun; 133(6):907-922. PubMed ID: 28357566
[TBL] [Abstract][Full Text] [Related]
73. The role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementia.
Mackenzie IR; Rademakers R
Curr Opin Neurol; 2008 Dec; 21(6):693-700. PubMed ID: 18989115
[TBL] [Abstract][Full Text] [Related]
74. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis.
Kabashi E; Valdmanis PN; Dion P; Spiegelman D; McConkey BJ; Vande Velde C; Bouchard JP; Lacomblez L; Pochigaeva K; Salachas F; Pradat PF; Camu W; Meininger V; Dupre N; Rouleau GA
Nat Genet; 2008 May; 40(5):572-4. PubMed ID: 18372902
[TBL] [Abstract][Full Text] [Related]
75. Zn
Preethi S; Bharathi V; Patel BK
Int J Biol Macromol; 2021 Apr; 176():186-200. PubMed ID: 33577819
[TBL] [Abstract][Full Text] [Related]
76. Amyotrophic lateral sclerosis mutant TDP-43 may cause synaptic dysfunction through altered dendritic spine function.
Jiang T; Handley E; Brizuela M; Dawkins E; Lewis KEA; Clark RM; Dickson TC; Blizzard CA
Dis Model Mech; 2019 May; 12(5):. PubMed ID: 31036551
[TBL] [Abstract][Full Text] [Related]
77. Curcumin abolishes mutant TDP-43 induced excitability in a motoneuron-like cellular model of ALS.
Dong H; Xu L; Wu L; Wang X; Duan W; Li H; Li C
Neuroscience; 2014 Jul; 272():141-53. PubMed ID: 24785678
[TBL] [Abstract][Full Text] [Related]
78. TDP-43 mutation in familial amyotrophic lateral sclerosis.
Yokoseki A; Shiga A; Tan CF; Tagawa A; Kaneko H; Koyama A; Eguchi H; Tsujino A; Ikeuchi T; Kakita A; Okamoto K; Nishizawa M; Takahashi H; Onodera O
Ann Neurol; 2008 Apr; 63(4):538-42. PubMed ID: 18438952
[TBL] [Abstract][Full Text] [Related]
79. ALS and FTLD: two faces of TDP-43 proteinopathy.
Liscic RM; Grinberg LT; Zidar J; Gitcho MA; Cairns NJ
Eur J Neurol; 2008 Aug; 15(8):772-80. PubMed ID: 18684309
[TBL] [Abstract][Full Text] [Related]
80. Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72.
Murray ME; DeJesus-Hernandez M; Rutherford NJ; Baker M; Duara R; Graff-Radford NR; Wszolek ZK; Ferman TJ; Josephs KA; Boylan KB; Rademakers R; Dickson DW
Acta Neuropathol; 2011 Dec; 122(6):673-90. PubMed ID: 22083254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
